Judge Grills Amarin, FDA Over Off-Label Promo Statements
Law360, New York (July 7, 2015, 6:28 PM EDT) -- A New York federal judge on Tuesday appeared unlikely to immunize Amarin Pharma Inc. from punishment by the U.S. Food and Drug Administration for engaging in off-label promotion, while nonetheless suggesting...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
